For chronic, bothersome restless legs syndrome (RLS), the usual first-choice medicine is an alpha-2-delta ligand, most often gabapentin or pregabalin. Gabapentin enacarbil is the formulation with a strong AASM recommendation where available. These are generally preferred over dopamine drugs because long-term dopamine agonists can cause augmentation, meaning symptoms begin earlier in the day and progressively worsen.
Also check
iron status, especially serum ferritin and transferrin saturation. Iron replacement can be highly effective when iron stores are low. The current AASM guideline recommends gabapentinoids and emphasizes iron assessment and treatment (
AASM guideline).
Avoid or review potential triggers: caffeine, alcohol, sleep deprivation, and drugs such as some antihistamines, antidepressants, and dopamine-blocking antiemetics. Dopamine agonists such as pramipexole or ropinirole may still be used selectively, but are no longer preferred for routine long-term treatment because of augmentation risk.
Seek medical review promptly if symptoms are new, severe, occur with kidney disease or pregnancy, or you have daytime sleepiness, pain, numbness, or weakness.